[HTML][HTML] Under the umbrella of clinical pharmacology: inflammatory bowel disease, infliximab and adalimumab, and a bridge to an era of biosimilars

Z Petric, J Goncalves, P Paixao - Pharmaceutics, 2022 - mdpi.com
Monoclonal antibodies (MAbs) have revolutionized the treatment of many chronic
inflammatory diseases, including inflammatory bowel disease (IBD). IBD is a term that …

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars.

Z Petric, J Goncalves, P Paixao - Pharmaceutics, 2022 - search.ebscohost.com
Monoclonal antibodies (MAbs) have revolutionized the treatment of many chronic
inflammatory diseases, including inflammatory bowel disease (IBD). IBD is a term that …

[HTML][HTML] Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars

Z Petric, J Goncalves, P Paixao - Pharmaceutics, 2022 - ncbi.nlm.nih.gov
Monoclonal antibodies (MAbs) have revolutionized the treatment of many chronic
inflammatory diseases, including inflammatory bowel disease (IBD). IBD is a term that …

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars.

Z Petric, J Goncalves, P Paixao - Pharmaceutics, 2022 - europepmc.org
Monoclonal antibodies (MAbs) have revolutionized the treatment of many chronic
inflammatory diseases, including inflammatory bowel disease (IBD). IBD is a term that …

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars

Z Petric, J Goncalves, P Paixao - Pharmaceutics, 2022 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies (MAbs) have revolutionized the treatment of many chronic
inflammatory diseases, including inflammatory bowel disease (IBD). IBD is a term that …

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars

Z Petric, J Goncalves, P Paixao - Pharmaceutics, 2022 - search.proquest.com
Monoclonal antibodies (MAbs) have revolutionized the treatment of many chronic
inflammatory diseases, including inflammatory bowel disease (IBD). IBD is a term that …